|
Robustness of the 16-gene signature for prediction of recurrence-free interval in localized clear cell renal cell carcinoma. |
|
|
Research Funding - Genomic Health |
|
|
Research Funding - Genomic Health |
|
|
Employment - Genomic Health |
Stock and Other Ownership Interests - Genomic Health |
Patents, Royalties, Other Intellectual Property - Genomic Health |
|
|
Employment - Genomic Health |
Stock and Other Ownership Interests - Genomic Health |
|
|
Research Funding - Genomic Health |
|
|
Research Funding - Genomic Health |
|
|
Research Funding - Genomic Health |
|
|
No Relationships to Disclose |
|
|
Research Funding - Genomic Health |
|
|
Employment - Genomic Health |
Stock and Other Ownership Interests - Genomic Health |
|
|
Employment - Genomic Health |
Stock and Other Ownership Interests - Genomic Health |
|
|
Employment - Genomic Health |
Stock and Other Ownership Interests - Genomic Health |
Patents, Royalties, Other Intellectual Property - Genomic Health |
|
|
|
Stock and Other Ownership Interests - Pfizer |
|
|
|
Stock and Other Ownership Interests - Pfizer |
|
|
Research Funding - Genomic Health |
|
|
Employment - Genomic Health |
Stock and Other Ownership Interests - Genomic Health |
Patents, Royalties, Other Intellectual Property - Genomic Health |
|
|
Research Funding - Genomic Health |